Can We Predict the Sites of the Recurrence of Ovarian Cancer by F-18 FDG PET/CT Depending on CA-125 Level?


TURGUT B., ÇİFTÇİ E., ERTÜRK S. A., Cetin B., Aker H., HASBEK Z.

CURRENT MEDICAL IMAGING REVIEWS, vol.13, no.4, pp.431-437, 2017 (SCI-Expanded) identifier identifier

Abstract

Objectives: The purpose of the study is predicting the sites of the recurrence with PET/CT by serum CA-125 level and detecting the cut-off value of CA-125 for metastatic ovarian cancer (OC) in comparison with Fluorine-18 FDG PET/CT.